Latest News about KVUE
Recent news which mentions KVUE
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
November 08, 2024
From Benzinga
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales
November 07, 2024
From Benzinga
This Big New Development Could Be Bullish for Kenvue Stock
October 30, 2024
Tickers
KVUE
From Motley Fool
3 Dividend Stocks to Double Up on Right Now
October 27, 2024
From Motley Fool
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.
October 26, 2024
Tickers
KVUE
From Motley Fool
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months
October 26, 2024
Tickers
KVUE
From Motley Fool
What's Going On With Kenvue Stock Monday?
October 21, 2024
From Benzinga
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
October 21, 2024
From Benzinga
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
October 20, 2024
From Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
October 13, 2024
From Motley Fool
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
From Benzinga
P/E Ratio Insights for Kenvue
September 27, 2024
From Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
From Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
From Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
September 01, 2024
From Motley Fool
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
From Benzinga
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
August 30, 2024
From Benzinga
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
From Motley Fool
A Big CEO Move, Big Buffett Buys, and More
August 22, 2024
From Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
August 18, 2024
From Motley Fool
7 Stable Dividend Stocks to Scoop Up on Discount
August 12, 2024
From InvestorPlace
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
From Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in August
August 09, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.